BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8157041)

  • 1. The effect of probenecid on paracetamol metabolism and pharmacokinetics.
    Kamali F
    Eur J Clin Pharmacol; 1993; 45(6):551-3. PubMed ID: 8157041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of probenecid and paracetamol (acetaminophen) on zidovudine glucuronidation in human liver in vitro.
    Kamali F; Rawlins MD
    Biopharm Drug Dispos; 1992 Aug; 13(6):403-9. PubMed ID: 1391678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of acetaminophen and lorazepam glucuronidation in vitro by probenecid.
    von Moltke LL; Manis M; Harmatz JS; Poorman R; Greenblatt DJ
    Biopharm Drug Dispos; 1993 Mar; 14(2):119-30. PubMed ID: 8453022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of microsomal enzyme induction on paracetamol metabolism in man.
    Prescott LF; Critchley JA; Balali-Mood M; Pentland B
    Br J Clin Pharmacol; 1981 Aug; 12(2):149-53. PubMed ID: 7306429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of propranolol on paracetamol metabolism in man.
    Baraka OZ; Truman CA; Ford JM; Roberts CJ
    Br J Clin Pharmacol; 1990 Feb; 29(2):261-4. PubMed ID: 2306420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat.
    Savina PM; Brouwer KL
    Drug Metab Dispos; 1992; 20(4):496-501. PubMed ID: 1356724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation.
    Abernethy DR; Greenblatt DJ; Ameer B; Shader RI
    J Pharmacol Exp Ther; 1985 Aug; 234(2):345-9. PubMed ID: 4020675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the hepatic uptake of paracetamol sulphate by anionic compounds.
    Sakuma-Sawada N; Iida S; Mizuma T; Hayashi M; Awazu S
    J Pharm Pharmacol; 1997 Aug; 49(8):743-6. PubMed ID: 9379348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracetamol and metabolite pharmacokinetics in infants.
    van der Marel CD; Anderson BJ; van Lingen RA; Holford NH; Pluim MA; Jansman FG; van den Anker JN; Tibboel D
    Eur J Clin Pharmacol; 2003 Jul; 59(3):243-51. PubMed ID: 12761605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro mechanisms of probenecid-associated alterations in acetaminophen glucuronide hepatic disposition.
    Turner KC; Brouwer KL
    Drug Metab Dispos; 1997 Sep; 25(9):1017-21. PubMed ID: 9311615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of caffeine on paracetamol activation in rat and mouse liver microsomes.
    Liu J; Sato C; Shigesawa T; Kamiyama T; Tajiri K; Miyakawa H; Marumo F
    Xenobiotica; 1992 Apr; 22(4):433-7. PubMed ID: 1523864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol glucuronidation in vitro: potential implications of inhibition by probenecid.
    Matin B; Sherbini AA; Alam N; Harmatz JS; Greenblatt DJ
    J Pharm Pharmacol; 2019 Mar; 71(3):371-378. PubMed ID: 30417385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracetamol pharmacokinetics and metabolism in young women.
    Allegaert K; Peeters MY; Beleyn B; Smits A; Kulo A; van Calsteren K; Deprest J; de Hoon J; Knibbe CA
    BMC Anesthesiol; 2015 Nov; 15():163. PubMed ID: 26566962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of paracetamol metabolism in young adult and elderly males.
    Miners JO; Penhall R; Robson RA; Birkett DJ
    Eur J Clin Pharmacol; 1988; 35(2):157-60. PubMed ID: 3191934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contributions of various chloroquine salts to the biliary and urinary execretion of hepatic paracetamol conjugation metabolites in the rat.
    Oforah E; Anyogo S
    Drug Metabol Drug Interact; 2000; 16(2):129-41. PubMed ID: 10962645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonal distribution of paracetamol glucuronidation in the isolated perfused rat liver.
    Mitchell MC; Hamilton R; Wacker L; Branch RA
    Xenobiotica; 1989 Apr; 19(4):389-400. PubMed ID: 2501939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of malaria infection on paracetamol disposition in the rat.
    Mansor SM; Edwards G; Roberts PJ; Ward SA
    Biochem Pharmacol; 1991 Jun; 41(11):1707-11. PubMed ID: 2043159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of 2-methoxyestradiol glucuronidation by probenecid.
    Qian Y; Sherbini A; Matin B; Zhao Y; Castellot J; Greenblatt DJ
    J Pharm Pharmacol; 2015 Nov; 67(11):1585-92. PubMed ID: 26272356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chrysin on the formation of N-acetyl-p-benzoquinoneimine, a toxic metabolite of paracetamol in rats and isolated rat hepatocytes.
    Pingili RB; Pawar AK; Challa SR
    Chem Biol Interact; 2019 Apr; 302():123-134. PubMed ID: 30794797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of polysaccharide peptide (PSP) on in vivo sulphation and glucuronidation of paracetamol in the rat.
    Yeung JH; Chiu LC; Ooi VE
    Eur J Drug Metab Pharmacokinet; 1995; 20(4):287-92. PubMed ID: 8983934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.